title: Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?
authors: Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
authors: Rohit P
authors: RP
authors: Ojha
authors: James G
authors: JG
authors: Gurney
authors: Daniel M
authors: DM
authors: Green
mesh_terms: D018943:Anthracyclines / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D054715:Cardiotoxins / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000235:genetics*; D005260:Female; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D008297:Male; D026901:Membrane Transport Proteins / Q000235:genetics*; D008954:Models, Biological; D020641:Polymorphism, Single Nucleotide
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D054715:Cardiotoxins; D026901:Membrane Transport Proteins; C065171:cif nucleoside transporter; C110655:UDP-glucuronosyltransferase, UGT1A6; D014453:Glucuronosyltransferase